Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 613 results for "Tecfidera"

Biogen CEO Scangos to Step Down -- WSJ
Nasdaq

BRIEF-Biogen CEO to step down; sees FY rev of about $11.2-$11....

July 21 Biogen Inc Sees 2016 Gaap And Non * George a. Scangos, ph.d., to step down as CEO * Biogen inc says Q2 Tecfidera revenue of $987 million versus. $883.3 million in the same quarter last year * Sees 2016 non-gaap diluted eps is ... Reuters UK, 1 week ago
[x]  

17 images for Tecfidera

FiercePharma, 1 week ago
Bidness Etc, 1 month ago
Motley Fool, 3 months ago
European Pharmaceutical Review, 3 months ago
Finchannel.com, 3 months ago
Nasdaq, 3 months ago
Nasdaq, 3 months ago
Nasdaq, 3 months ago
Nasdaq, 3 months ago
TheStreet.com, 3 months ago

Opinion/decision on a Paediatric investigation plan (PIP): Tecfidera, Dimethyl fumarate, Therapeutic area: Neurology

| 30 Churchill Place, Canary Wharf, London E14 5EU, United Kingdom . Tel. +44 (0)20 3660 6000 . Fax +44
 European Medicines Agency1 week ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 7, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency2 weeks ago

Biogen Optionality Looking Attractive; Bernstein Initiates At Outperform

Biogen Inc (NASDAQ: BIIB ) has an aging MS franchise, but a solid biosimilar pipeline is sure to offset the loss of Tecfidera, Avonex and Tysabri. Bernstein's Aaron Gal initiated Biogen at outperform and set a price target of $282. The multiple ...
 Benzinga.com4 weeks ago

New Data at CMSC Assess Real-World Impact of Rebif® (interferon beta-1a) in People with Relapsing MS

- Data compare Rebif vs. Tecfidera® and Aubagio® in the first year of treatment - Assessments include likelihood of relapse, medical costs and outpatient management resources needs 09:00 ET from EMD Serono ROCKLAND, Mass., June 2, 2016 ...
 PR Newswire1 month ago EMD Serono Release: New Data At Assess Real-World Impact Of Rebif (Interferon Beta-1a) In People With Relapsing MS  BioSpace1 month ago
[x]  
FiercePharma

Biogen's top commercial exec leaves amid Tecfidera sales trouble

When a top biopharma executive abruptly shoves off, what comes next? Questions. Make that departing exec a sales-and-marketing chief, and couple that departure with slowing sales of a key product, and the questions multiply. Tony Kingsley That's ...
 FiercePharma1 week ago
Reuters UK

Onset of Parkinson's Disease May Be Slowed by Metabolite in MS Drug, Mouse Study Shows

Dimethylfumarate (Tecfidera), a drug used to harness multiple sclerosis symptoms, generates a metabolite that could be used in Parkinson's patients to improve defenses against oxidative damage. The drug actson Nrf2, a molecule that has frequently ...
 Parkinson'sNewsToday.com1 month ago Biogen's MS Drug Fails to Meet Goals in Study  Bioscience Technology Online1 month ago Biogen's MS drug misses main goal in mid-stage study  Yahoo! India1 month ago UPDATE 2-Biogens MS drug misses main goal in mid-stage study  Reuters UK1 month ago
[x]  
American Banking News - Earnings

Biogen Inc. (BIIB) Earns Neutral Rating from Robert W. Baird

Robert W. Baird reissued their neutral rating on shares of Biogen Inc. (NASDAQ:BIIB) in a research note released on Monday morning. They currently have a $268.00 target price on the biotechnology company's stock. Shares of Biogen (NASDAQ:BIIB) ...
 WKRB News1 day ago Biogen's (BIIB) Hold Rating Reaffirmed at Credit Suisse Group AG  Mideast Time1 day ago Biogen Inc. (BIIB) Upgraded to Hold by Vetr Inc.  Zolmax News1 day ago Biogen Inc. (BIIB) Stock Rating Reaffirmed by Robert W. Baird  Mideast Time2 days ago
[x]  

Jamie-Lynn Sigler: Multiple Sclerosis Is Part Of Me, But It's Not Who I Am

Jamie-Lynn Sigler, the actress best known for playing the role of Tony Soprano's daughter in the Emmy award-winning TV drama The Sopranos , has revealed a personal secret that she has been hiding from the public. According to the Sydney Morning ...
 Inquisitr6 hours ago

Rosenbaum Jay D. Takes Position in Biogen Inc. (BIIB)

Rosenbaum Jay D. bought a new stake in shares of Biogen Inc. (NASDAQ:BIIB) during the second quarter, Holdings Channel reports. The institutional investor bought 1,039 shares of the biotechnology company's stock, valued at approximately $251,000. ...
 Mideast Time6 hours ago Babson Capital Management LLC Cuts Position in Biogen Inc. (BIIB)  WKRB News2 days ago Sector Gamma AS Acquires 6,610 Shares of Biogen Inc. (BIIB)  WKRB News2 days ago Biogen Inc. (BIIB) Shares Sold by Silvercrest Asset Management Group LLC  Mideast Time3 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Tecfidera
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less